XML 40 R20.htm IDEA: XBRL DOCUMENT
v3.24.1

Summary of Significant Accounting Policies (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Accounting Policies [Abstract] |
Schedule of the Error Correction | A summary of corrections reflecting the prior period impact to the Company’s Consolidated Statement of Operations, for the year ended December 31, 2022, are shown below: Schedule of the Error Correction
|  | December 31, 2022 |  |  | Correction |  |  | As Corrected December 31, 2022 |
General and administrative expense |  | $ | 198,978 |  |  | $ | 339,818 |  |  | $ | 538,796 |
Research and development expense |  |  | 1,488,530 |  |  |  | (339,818 | ) |  |  | 1,148,712 |
Net Loss |  | $ | 1,687,508 |  |  | $ | - |  |  | $ | 1,687,508 |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents include cash in bank accounts and money market funds with maturities of less than three months from inception, which are readily convertible to known amounts of cash and which, in the opinion of management, are subject to an insignificant risk of loss in value. As of December 31, 2023 and 2022, cash and cash equivalents consisted of the following: Schedule of Cash and Cash Equivalents
|  | December 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Cash |  | $ | 1,550,098 |  |  | $ | 5,411,378 |
Money market funds |  |  | 1,026,318 |  |  |  | 3,005,825 |
Total cash and cash equivalents |  | $ | 2,576,416 |  |  | $ | 8,417,203 |
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis | Set out below are the Company’s financial instruments that are required to be remeasured at fair value on a recurring basis and their fair value hierarchy as of December 31, 2023 (none for December 31, 2022): Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
December 31, 2023 |  | Level 1 |  |  | Level 2 |  |  | Level 3 |  |  | Carrying Value |
Assets |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Marketable Securities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
United States Treasury Bonds |  | $ | 2,887,215 |  |  | $ | - |  |  | $ | - |  |  | $ | 2,887,215 |
Total Assets |  | $ | 2,887,215 |  |  | $ | - |  |  | $ | - |  |  | $ | 2,887,215 |
Liabilities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Derivative Liability - Warrants |  | $ | - |  |  | $ | - |  |  | $ | 410,660 |  |  | $ | 410,660 |
Derivative Liability - Accelerated feature |  |  | - |  |  |  | - |  |  |  | 3,852 |  |  |  | 3,852 |
Total Liabilities |  | $ | - |  |  | $ | - |  |  | $ | 414,512 |  |  | $ | 414,512 |
Schedule of Useful Lives for Property Plant Equipment | Schedule of Useful Lives for Property Plant Equipment
Furniture |  |  | 5 years |
Computers and equipment |  |  | 5 years |
Research Equipment |  |  | 10 years |
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share | For the years ended December 31, 2023 and 2022, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share
|  | December 31, |  |  | December 31, |
|  | 2023 |  |  | 2022 |
Convertible notes (Note 5) |  |  | 959,513 |  |  |  | - |
Warrant (Note 6) |  |  | 1,446,155 |  |  |  | 356,810 |
Restricted stock units (Note 6) |  |  | 197,855 |  |  |  | - |
|  |  | 2,603,523 |  |  |  | 356,810 |

X
- Definition Schedule of Useful Lives for Property Plant Equipment [Table Text Block] + References No definition available. + Details
Name: | SHPH_ScheduleOfUsefulLivesForPropertyPlantEquipmentTableTextBlock
Namespace Prefix: | SHPH_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of prior period adjustments to previously issued financial statements including (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustments (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 7 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9 + Details
Name: | us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration